DALLAS & WASHINGTON--(BUSINESS WIRE)--Quotient Wealth Partners (“Quotient”) and TritonPoint Wealth (“TritonPoint”), today announced a joint partnership with Opto Investments, a technology-driven ...
NOTTINGHAM, England, Dec. 4, 2025 /PRNewswire/ -- Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Intrepid Labs, the AI leader in pharmaceutical ...
Quotient Sciences and Biorasi have established a partnership to expedite early phase clinical trials to patient proof of concept (PoC). The collaboration merges Quotient Sciences' early clinical ...